封面
市場調查報告書
商品編碼
1970165

全球愛滋病毒自檢檢測套組市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global HIV Self-Test Kits Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 134 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年,愛滋病毒自檢檢測套組市場規模將達到 15.5117 億美元,高於 2025 年的 3.5865 億美元,預計從 2026 年到 2034 年的複合年成長率將達到 17.67%。

隨著醫療系統和消費者對快速、私密且便捷的診斷解決方案的需求日益成長,愛滋病毒自檢檢測套組市場預計將會成長。未來的試劑盒將整合微流體技術、生物感測器和人工智慧輔助解讀演算法,以提高準確性、可靠性和易用性。與行動應用程式和遠端醫療平台的整合將實現即時指導、報告和醫療保健整合。

創新之處包括可同時檢測多種合併感染的多功能檢測套組、簡化的檢體採集方法以及改進的檢測技術。與預測分析和雲端健康監測平台的整合,提升了人群篩檢、早期診斷和流行病學追蹤的效率。永續包裝和環保試劑的使用,有助於符合環境法規和法律要求。

未來的成長將受到公共衛生政策、宣傳宣傳活動以及對便捷易用的檢測方案的需求的推動。透過結合先進的診斷技術、人工智慧輔助的結果解讀以及與數位醫療的融合,愛滋病毒自檢檢測套組將有助於早期發現、增強患者自主性並促進全球疾病控制工作。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球愛滋病毒自檢檢測套組市場:依技術分類

  • 市場分析、洞察與預測
  • 側向流動免疫檢測
  • 免疫過濾法
  • 螢光層析法

第5章:全球愛滋病毒自檢檢測套組市場:依檢體類型分類

  • 市場分析、洞察與預測
  • 口腔液
  • 尿

第6章 全球愛滋病毒自檢檢測套組市場:依檢測世代分類

  • 市場分析、洞察與預測
  • 第二代
  • 第三代

第7章 全球愛滋病毒自檢檢測套組市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • OraSure TechnologiesInc
    • Chembio Diagnostic Systems
    • Atomo Diagnostics
    • BioSure UK
    • Biosynex Group
    • BioLytical Laboratories Inc
    • Orange Life
    • Bedfordbiotech
    • Sedia Biosciences Corporation
簡介目錄
Product Code: VMR11212384

The HIV Self-Test Kits Market size is expected to reach USD 1551.17 Million in 2034 from USD 358.65 Million (2025) growing at a CAGR of 17.67% during 2026-2034.

The HIV self-test kits market is set for growth as healthcare systems and consumers embrace rapid, private, and accessible diagnostic solutions. Future kits will integrate microfluidics, biosensors, and AI-assisted interpretation algorithms to enhance accuracy, reliability, and user-friendliness. Connectivity with mobile apps and telemedicine platforms will enable real-time guidance, reporting, and linkage to care.

Emerging innovations include multiplexed kits for simultaneous detection of co-infections, simplified sampling methods, and enhanced sensitivity detection. Integration with predictive analytics and cloud-based health monitoring platforms will improve population-level screening, early diagnosis, and epidemiological tracking. Sustainable packaging and eco-friendly reagents will support environmental and regulatory compliance.

Future growth will be driven by public health initiatives, awareness campaigns, and the need for convenient, accessible testing solutions. By combining advanced diagnostics, AI-assisted interpretation, and digital health integration, HIV self-test kits will enhance early detection, patient autonomy, and global disease management efforts.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • Lateral Flow Immunoassay
  • Immunofiltration
  • Fluorescent Chromatography

By Specimen Type

  • Blood
  • Oral Fluid
  • Urine

By Test Generation

  • Second Generation
  • Third Generation

COMPANIES PROFILED

  • OraSure Technologies, Inc, Chembio Diagnostic Systems, Atomo Diagnostics, BioSure UK, Biosynex Group, bioLytical Laboratories Inc, Orange Life, Bedfordbiotech, Sedia Biosciences Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HIV SELF-TEST KITS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Lateral Flow Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Immunofiltration Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Fluorescent Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HIV SELF-TEST KITS MARKET: BY SPECIMEN TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Specimen Type
  • 5.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Oral Fluid Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HIV SELF-TEST KITS MARKET: BY TEST GENERATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Test Generation
  • 6.2. Second Generation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Third Generation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HIV SELF-TEST KITS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Technology
    • 7.2.2 By Specimen Type
    • 7.2.3 By Test Generation
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Technology
    • 7.3.2 By Specimen Type
    • 7.3.3 By Test Generation
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Technology
    • 7.4.2 By Specimen Type
    • 7.4.3 By Test Generation
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Technology
    • 7.5.2 By Specimen Type
    • 7.5.3 By Test Generation
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Technology
    • 7.6.2 By Specimen Type
    • 7.6.3 By Test Generation
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HIV SELF-TEST KITS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 OraSure TechnologiesInc
    • 9.2.2 Chembio Diagnostic Systems
    • 9.2.3 Atomo Diagnostics
    • 9.2.4 BioSure UK
    • 9.2.5 Biosynex Group
    • 9.2.6 BioLytical Laboratories Inc
    • 9.2.7 Orange Life
    • 9.2.8 Bedfordbiotech
    • 9.2.9 Sedia Biosciences Corporation